Top Tweets for #RESILIAtissue
Have you seen the latest data in support of #RESILIAtissue valves? The #mitral cohort of the #COMMENCEtrial showed excellent outcomes at 5 years, with 98.7% freedom from structural valve deterioration (#SVD). Visit the blog for the clinical summary at https://t.co/IFfG7H388Z
It’s here! Five-year data from the first clinical data of #RESILIAtissue valves in the #mitral position. Results from the #COMMENCE #mitral trial show a favorable safety profile and clinically stable hemodynamic performance. Learn more https://t.co/sZfFUhlhyb
Just in from #AATS2023: Surgical aortic valves with #RESILIAtissue show excellent outcomes and durability at 7 years in the #COMMENCEaortictrial.* Review all the data, including hemodynamics, reintervention rates, and rates of TVL at https://t.co/MhSDrGJ47F
Just in from #AATS2023: Surgical aortic valves with #RESILIAtissue show excellent outcomes and durability at 7 years in the #COMMENCEaortictrial.* Review all the data, including hemodynamics, reintervention rates, and rates of TVL at https://t.co/7MgsrZbCOf
The latest results from the #COMMENCEaortictrial were just presented at #AATS2023. #RESILIAtissue demonstrated excellent outcomes in a study of younger patients - 65.1 mean age, with 99.3% freedom from #SVD at 7 years.* Learn more at https://t.co/dLhGLZBtkM
Attending #AATS2023? Come by our booth to experience our #RESILIAtissue interactive model, learn more about our RESILIA tissue portfolio, and explore the latest data. We look forward to talking with you!
Are you at #STS2023? Come by our booth to dive deeper into #RESILIAtissue with our interactive experience and explore more about our products made with RESILIA tissue backed by clinical data. We look forward to talking with you.
#RESILIAtissue gives #surgeons the freedom to offer a resilient tissue alternative that brings the quality-of-life benefits of #tissuevalves to patients.* Learn more in our latest blog post https://t.co/vb0IBqh5qF
When it comes to valve selection, durability matters. That’s why the INSPIRIS #RESILIAtissue valve is designed with enhanced** tissue anti-calcification technology that will potentially allow the valve to last longer. Learn more https://t.co/QrwQ7eormz #cardiacsurgeons
@EdwardsLifesci is proud to announce that intermediate-term results from the COMMENCE trial have been published in #JTCVS. Through 4 yrs follow up, #RESILIAtissue #valve had 0 cases of #structuralvalvedeterioration out of 689 patients. https://t.co/z061zmKocQ
Last Seen Hashtags on Sotwe
robloxcondo
Seen from Saudi Arabia
หลุดนักเรียน
Seen from Thailand
fpemonarchau
Seen from United States
momson #nolimit
Seen from United States
corninhos
Seen from Brazil
monkeyappwins
Seen from United States
รับงานลำลูกกา
Seen from Thailand
valeng222
Seen from Colombia
cheesyforeskin
hstud
Seen from Mexico
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
119.2M followers
Cristiano Ronaldo
@cristiano
112M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.2M followers
KATY PERRY
@katyperry
88.4M followers
Taylor Swift
@taylorswift13
82.3M followers
Lady Gaga
@ladygaga
73.8M followers
Virat Kohli
@imvkohli
71.1M followers
Kim Kardashian
@kimkardashian
70.2M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.3M followers
Neymar Jr
@neymarjr
64M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.5M followers
X
@x
60.8M followers